| 产品名称 | 产品编号 | CAS编号 | 分子式 = 分子量 | 位单 | 联系QQ |
| Tideglusib; Tideglusib | CFN60383 | 865854-05-3 | C19H14N2O2S = 334.39 | 5mg | QQ客服：2159513211 |
| IKK-16 (IKK Inhibitor VII); IKK-16 (IKK Inhibitor VII) | CFN60384 | 873225-46-8 | C28H29N5OS = 483.63 | 5mg | QQ客服：2056216494 |
| GDC-0152; GDC-0152 | CFN60385 | 873652-48-3 | C25H34N6O3S = 498.64 | 5mg | QQ客服：1457312923 |
| Omecamtiv mecarbil (CK-1827452); Omecamtiv mecarbil (CK-1827452) | CFN60386 | 873697-71-3 | C20H24FN5O3 = 401.43 | 5mg | QQ客服：2056216494 |
| AZ 628; AZ 628 | CFN60387 | 878739-06-1 | C27H25N5O2 = 451.52 | 5mg | QQ客服：1413575084 |
| P5091 (P005091); P5091 (P005091) | CFN60388 | 882257-11-6 | C12H7Cl2NO3S2 = 348.22 | 5mg | QQ客服：215959384 |
| CCT128930; CCT128930 | CFN60389 | 885499-61-6 | C18H20ClN5 = 341.84 | 5mg | QQ客服：2056216494 |
| AT9283; AT9283 | CFN60390 | 896466-04-9 | C19H23N7O2 = 381.43 | 5mg | QQ客服：2056216494 |
| Tirbanibulin (KX2-391); Tirbanibulin (KX2-391) | CFN60391 | 897016-82-9 | C26H29N3O3 = 431.53 | 5mg | QQ客服：1457312923 |
| AS-252424; AS-252424 | CFN60392 | 900515-16-4 | C14H8FNO4S = 305.28 | 5mg | QQ客服：1413575084 |
| 福他替尼; Fostamatinib | CFN60393 | 901119-35-5 | C23H26FN6O9P = 580.46 | 5mg | QQ客服：215959384 |
| 比卡鲁胺; Bicalutamide | CFN60394 | 90357-06-5 | C18H14F4N2O4S = 430.37 | 5mg | QQ客服：1457312923 |
| Tivantinib (ARQ 197); Tivantinib (ARQ 197) | CFN60395 | 905854-02-6 | C23H19N3O2 = 369.42 | 5mg | QQ客服：3257982914 |
| SC75741 ; SC75741 | CFN60396 | 913822-46-5 | C29H23N7O2S2 = 565.67 | 5mg | QQ客服：2159513211 |
| 瑞法替尼; Refametinib (RDEA119) | CFN60397 | 923032-37-5 | C19H20F3IN2O5S = 572.34 | 5mg | QQ客服：2159513211 |
Cell. 2018 Jan 11;172(1-2):249-261.e12. doi: 10.1016/j.cell.2017.12.019.IF=36.216(2019)
Cell Metab. 2020 Mar 3;31(3):534-548.e5. doi: 10.1016/j.cmet.2020.01.002.IF=22.415(2019)
Mol Cell. 2017 Nov 16;68(4):673-685.e6. doi: 10.1016/j.molcel.2017.10.022.IF=14.548(2019)
ACS Nano. 2018 Apr 24;12(4): 3385-3396. doi: 10.1021/acsnano.7b08969.IF=13.903(2019)
Nature Plants. 2016 Dec 22;3: 16206. doi: 10.1038/nplants.2016.205.IF=13.297(2019)
Sci Adv. 2018 Oct 24;4(10): eaat6994. doi: 10.1126/sciadv.aat6994.IF=12.804(2019)